We believe that people with Down syndrome should be prioritised in the COVID-19 vaccination rollout.

We are working hard to support the global Down syndrome population to advocate for this necessary prioritisation.

We have produced two webinars:

---

Evidence on vaccine prioritisation for people with Down syndrome

In our first webinar, Professor André Strydom, President of the Trisomy 21 Research Society (T21RS), answers questions from our global community about COVID-19 and the vaccines in relation to people with Down syndrome.

---

Advocating for vaccine prioritisation for people with Down syndrome

In our second webinar, we present our new COVID-19 Vaccination Prioritisation Advocacy Toolkit, including advocacy tools and evidence.

We then have presentations from two DSi member organisations with experience of advocating for the prioritisation of people with Down syndrome for vaccinations in their countries.

Finally, we offer a space to ask questions of the speakers.